Quipt Home Medical (Nasdaq: QIPT) reported a … [Read more...]
Resmed Allays Tariff Concerns, Reports Strong Revenue Growth in Q3 Earnings Call
CEO Mick Farrell credited “excellent top line and bottom line results” to the company’s “disciplined execution to capture growing demand for our products.”
Resmed CEO Mick Farrell (NYSE: RMD) reported … [Read more...]
CMS Proposes Medicare, Medicaid Coverage for Anti-Obesity Drugs
The Centers for Medicare & Medicaid Services’ proposed rule will be published in the Federal Register on Dec. 10.
The Centers for Medicare & Medicaid Services … [Read more...]
ResMed Reports Strong Q4 2024 Financial Results, Views GLP-1s as Tailwind for Sleep Therapy Business
The company is using digital health platforms to support patient engagement and adherence to therapy.
ResMed Inc. (NYSE: RMD) reported strong growth in … [Read more...]
Owens & Minor Continues to Tout Rotech Acquisition, $5 Billion Goal for Patient-Direct Business Segment
Owens & Minor reports already receiving positive feedback.
It’s still very early in respect to the amount of … [Read more...]